Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach
Metformin is a commonly prescribed antihyperglycemic drug, and has been investigated in vivo and in vitro for its effect to improve the comorbidity of diabetes and various types of cancers. Several studies investigated the therapeutic mechanisms of metformin on cancer cells, but the exact mechanism...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2017-10-01
|
| Edice: | Frontiers in Public Health |
| Témata: | |
| On-line přístup: | http://journal.frontiersin.org/article/10.3389/fpubh.2017.00277/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|